Key result
Truncated abstract obscures results on hepatic triglycerides and myocardial metabolism in type 2 diabetes.
Why the study?
Heart disease is the leading cause of mortality in T2DM, and central obesity and hepatic steatosis are related to increased heart disease risk, but the relationship between hepatic triglyceride content and myocardial function and metabolism remained unclear.
Observational (n=61)
Answers are grounded in this paper and cite their sources.
Shows hepatic triglyceride content influences myocardial metabolism in type 2 diabetes, suggesting potential metabolic interventions.
Objectives: The purpose of this study was to investigate the relationship between hepatic triglyceride content and both myocardial function and metabolism in type 2 diabetes mellitus (T2DM). Background: Heart disease is the leading cause of mortality in T2DM. Central obesity and hepatic steatosis, both hallmark abnormalities in T2DM, have been related to increased risk of heart disease. Methods: Sixty-one T2DM patients underwent myocardial perfusion and substrate metabolism measurements by positron emission tomography, using [
No takes yet. Share an insight, caveat, or question.
Rijzewijk et al. (2010) conducted an observational in Type 2 diabetes mellitus (n=61). Hepatic triglyceride content was evaluated on Myocardial function and metabolism. The relationship between hepatic triglyceride content and myocardial metabolism in type 2 diabetes was investigated, but results are not available due to a truncated abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: